These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 15289731)
1. Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement. Oberfield RA; Sampson E; Heatley GJ Am J Clin Oncol; 2004 Aug; 27(4):376-83. PubMed ID: 15289731 [TBL] [Abstract][Full Text] [Related]
2. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion. Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673 [TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Barone RM; Byfield JE; Goldfarb PB; Frankel S; Ginn C; Greer S Cancer; 1982 Sep; 50(5):850-62. PubMed ID: 6212114 [TBL] [Abstract][Full Text] [Related]
4. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. ; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003 [TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315 [TBL] [Abstract][Full Text] [Related]
6. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089 [TBL] [Abstract][Full Text] [Related]
7. Complications of hepatic artery infusion: a review of 4580 reported cases. Barnett KT; Malafa MP Int J Gastrointest Cancer; 2001; 30(3):147-60. PubMed ID: 12540027 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Aldrighetti L; Arru M; Angeli E; Venturini M; Salvioni M; Ronzoni M; Caterini R; Ferla G Hepatogastroenterology; 2002; 49(44):513-7. PubMed ID: 11995485 [TBL] [Abstract][Full Text] [Related]
9. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Heinrich S; Petrowsky H; Schwinnen I; Staib-Sebler E; Gog C; El-Ganainy A; Gutt C; Müller HH; Lorenz M Surgery; 2003 Jan; 133(1):40-8. PubMed ID: 12563236 [TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M; Müller HH J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236 [TBL] [Abstract][Full Text] [Related]
11. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study. Bertuccelli M; Falcone A; Campoccia S; Conti M; Brunetti I; Caramella D; Giulianotti PC; Mosca F; Bartolozzi C; Conte PF Tumori; 1999; 85(6):473-7. PubMed ID: 10774568 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336 [TBL] [Abstract][Full Text] [Related]
14. In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer. Kemeny N J Natl Compr Canc Netw; 2010 May; 8(5):507-9. PubMed ID: 20495081 [No Abstract] [Full Text] [Related]
15. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590 [TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075 [TBL] [Abstract][Full Text] [Related]